Question

In: Math

A new drug for pain relief is being tested within a given palliative care population. The...

A new drug for pain relief is being tested within a given palliative care population. The new drug is being compared to an already approved pain relief drug that is commonly used in providing palliative care to patients who experience chronic severe pain. Assume the patients are asked to rate the pain on a scale from 1 to 10, and the data presented below was obtained from a small study designed to compare the effectiveness of the two drugs. Set up and interpret the results of a Mann-Whitney U test with an alpha of .05.

                        Pain Rating as Reported by Patients

Old Drug           1          3          3          4          6         

New Drug         1          2          3          3          7

Old Drug

New Drug

Total Sample

(Ordered Smallest to Largest)

Ranks

Old Drug

New Drug

Old Drug

New Drug

R1=

R2=

A) We fail to reject H0, which states the two populations are equal at the alpha equals .05 level because the calculated U value of 10.5 is greater than the critical U value of 2.

B) We fail to reject H0, which states the two populations are equal at the alpha equals .05 level because the calculated U value of 14.5 is greater than the critical U value of 2.

C) We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05 level because the calculated U value of 10.5 is greater than the critical U value of 2.

D) We reject H0 in favor of H1, which states the two populations are not equal at the alpha equals .05 level because the calculated U value of 14.5 is greater than the critical U value of 2.

Solutions

Expert Solution

B) We fail to reject H0 in favour of H1, which states the two populations are equal at the alpha equals .05 level because the calculated U value of 14.5 is greater than the critical U value of 2.

R RGUI (64-bit) File Edit Packages Windows Help EPHO RR Console X R Untitled-R Editor > 1-pf (9.33,2,36) [1] 0.0005437405 > round (1-pf (9.33,2,36),4) [1 5e-04 > old=c (1,3,3,4,6) old c (1,3, 3,4,6) new-c (1,2, 3, 3,7) wilcox.test (old, new, paired=F) > new=c (1,2,3,3,7) >wilcox.test (old, new, paired=F) Wilcoxon rank sum test with continuity correction old and new data w = 14.5, p-value = 0.7457 alternative hypothesis: true location shift is not equal to 0 Warning message: In wilcox.test.default (old, new, paired = F): cannot compute exact p-value with ties


Related Solutions

Use SAS to answer the question: A drug company tested three formulations of a pain relief...
Use SAS to answer the question: A drug company tested three formulations of a pain relief medicine for migraine headache sufferers. For the experiment 27 volunteers were selected and 9 were randomly assigned to one of three drug formulations. The subjects were instructed to take the drug during their next migraine headache episode and to report their pain on a scale of 1 to 10 (10 being most pain) Drug A: 4 5 4 3 2 4 3 4 4...
A drug company tested three formulations of a pain relief medicine for migraine headache sufferers. For...
A drug company tested three formulations of a pain relief medicine for migraine headache sufferers. For the experiment 27 volunteers were selected and 9 were randomly assigned to one of three drug formulations. The subjects were instructed to take the drug during their next migraine headache episode and to report their pain on a scale of 1 to 10 (10 being most pain). Drug A Drug B Drug C 4 6 6 5 8 7 4 4 6 3 5...
Problem 1. A drug company tested three formulations of a pain relief medicine for migraine headache...
Problem 1. A drug company tested three formulations of a pain relief medicine for migraine headache sufferers. For the experiment 27 volunteers were selected and 9 were randomly assigned to one of three drug formulations. The subjects were instructed to take the drug during their next migraine headache episode and to report their pain on a scale of 1 to 10 (10 being most pain).              Drug A 4 5 4 3 2 4 3 4 4              Drug B 6 8...
A drug company is marketing a new pain relief formula in 800 mg. tablets. The company...
A drug company is marketing a new pain relief formula in 800 mg. tablets. The company claims that on the average 2.6 of the tablets will eliminate a migraine headache. A neurologist asks 36 of her patients with migraines to keep track of how many of the new tablets are needed to get relief from their next migraine. Her patients have an average of 3.1 tablets with a standard deviation of 1.1. Can the neurologist conclude at the 0.05 level...
Aged residents living with dementia, palliative care and pain assessments?
Aged residents living with dementia, palliative care and pain assessments?
The length of pain relief from the drug Tramadol is known to be normally distributed. The...
The length of pain relief from the drug Tramadol is known to be normally distributed. The pharmaceutical company that makes Tramadol claims that the average pain relief lasts longer than 4 hours. A random sample of 15 patients on Tramadol had a mean of 4.28 hours and a standard deviation of 0.5 hours. a) State the hypotheses b) State the rejection region for 훼=0.025 c) Perform a Student’s T-test and state your conclusion. d) The p-value for this sample will...
Exercise 3.11 A new drug is being used to relieve the pain of arthritis. However, the...
Exercise 3.11 A new drug is being used to relieve the pain of arthritis. However, the drug may reduce a patient’s heartbeat too much. To investigate the drugs effect on a person’s heartbeat, different dosages of the drug were given to six patients, and 30 minutes later, the decrease in each patient’s heartbeat was recorded. Dosage X = (2.0, 1.5, 3.0, 2.5, 4.0, 3.0) measured in ml.?Decrease Y = (15, 20, 18, 16, 19, 17) measured in beat per minute...
Use SPSS for this Application Exercise: A pharmaceutical company tested three formulations of a pain relief...
Use SPSS for this Application Exercise: A pharmaceutical company tested three formulations of a pain relief medicine for migraine headache sufferers. Volunteers were selected and randomly assigned to one of the three drug formulations. The volunteers were instructed to take the drug during their next migraine headache episode and to report their pain on a scale of 1 to 10 (10 being most pain). The data are below. What can be concluded with ? = 0.05? formulation A formulation B...
A pharmaceutical company tested three formulations of a pain relief medicine for migraine headache sufferers. For...
A pharmaceutical company tested three formulations of a pain relief medicine for migraine headache sufferers. For the experiment, 88 volunteers were randomly assigned to one of three drug formulations. The subjects were instructed to take the drug during their next migraine headache episode and to report their pain level on a Likert scale of 1 (no pain) to 10 (extreme pain) 30 minutes after taking the drug. Is there a significant difference in the mean pain level for at least...
A pharmaceutical company tested three formulations of a pain relief medicine for migraine headache sufferers. For...
A pharmaceutical company tested three formulations of a pain relief medicine for migraine headache sufferers. For the experiment, 27 volunteers were selected and 9 were randomly assigned to one of three drug formulations. The subjects were instructed to take the drug during their next migraine headache episode and to report their pain on a scale of 1 = no pain to 10 = extreme pain 30 minutes after taking the drug. a. Identify the response variable for this experiment. __________________________________(2)...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT